Secondary endpointThe secondary endpoints are the incidence of CIN(defined as an absolute rise of ≥0.5 mg/dL or a relativeincrease of ≥25% in serum creatinine over baselinewithin 48 to 72 h after contrast administration), rehospitalization, hemodialysis, and mortality within 6 weeksafter contrast administration.